<DOC>
	<DOCNO>NCT02189824</DOCNO>
	<brief_summary>A phase 1 study infusion partially HLA match unrelated donor blood marrow cell ( microtransplantation ) follow consolidation chemotherapy patient AML suitable allogenic stem cell transplantation .</brief_summary>
	<brief_title>Chemotherapy Followed Infusion Partially HLA Matched Unrelated Donor Cells Patients With AML Who Are Ineligible Stem Cell Transplantation</brief_title>
	<detailed_description>To determine safety tolerability co-administration partially HLA antigen match unrelated donor cryopreserved donor lymphocyte ( microtransplantation ) chemotherapy patient high risk acute myeloid leukaemia ineligible unsuitable high dose chemotherapy stem cell transplantation .</detailed_description>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>1 . Newly diagnose AML consider suitable allogenic stem cell transplant basis age comorbidities 2 . Complete morphological remission follow 12 cycle induction chemotherapy consist anthracycline/cytosine arabinoside combination 3 . Availability cryopreserved donor stem cell bone marrow appropriate HLA match 4 . Adequate hepatic renal function 5 . Estimated life expectancy least 6 month 6 . Patient give informed consent event patient able give inform consent , consent give accord hospital procedure force time trial 1 . Patient morphological remission follow 2 cycle induction chemotherapy 2 . Use fludarabine purine analogue remission induction use major immunosuppressive medication immunomodulatory agent include thalidomide , lenalidomide , azacitidine immediately prior concurrent administration chemotherapy AML 3 month administration partially HLA match 3rd party cell 3 . Absence cryopreserved donor stem cell bone marrow product appropriate matching 4 . Presence significant hepatic , renal major organ dysfunction 5 . Uncontrolled infection bleed prior commencement consolidation chemotherapy 6 . Privately insured outpatient day consent sign day cryopreserved partially HLA match donor cell infuse</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>